Lifecore Biomedical to Participate at DCAT Week 2026

Company Overview - Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO) specializing in sterile injectable pharmaceutical products, including complex formulations [2] - The company has over 40 years of expertise in manufacturing premium, injectable-grade hyaluronic acid and serves global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories [2] Upcoming Event - Lifecore will participate in DCAT Week 2026, scheduled for March 23-26, 2026, in New York City [1] - The company will host customers and prospective partners to discuss development and manufacturing solutions for existing and new injectable programs during the conference [1]